NASDAQ:ELDN

Eledon Pharmaceuticals Stock Insider Trading

etoro logo Buy ELDN
*Your capital is at risk
$3.38
-0.0300 (-0.88%)
At Close: Jul 31, 2026

Eledon Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 48.88M and sold 0 ELDN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 48.88M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 10, 2025
Buy
Restricted Stock Units
A-Award
Hillson Jan
Director
Director 3 430
Value: $13.9K
Jan 10, 2025
Buy
Stock Option (right to buy)
A-Award
Hillson Jan
Director
Director 30 870
Value: $124.7K
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Little Paul Sean
Chief Financial Officer
C-Suite Officer 525 032
Value: $1.21M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Perrin Steven
President
CEO / President 840 438
Value: $1.93M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Smith Bryan E.
General Counsel, Corporate Sec
Officer 474 350
Value: $1.09M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Gros David-alexandre C
Chief Executive Officer
CEO / President 1 015 743
Value: $2.34M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Gros David-alexandre C
Chief Executive Officer
CEO / President 1 015 743
Value: $2.34M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Smith Bryan E.
General Counsel, Corporate Sec
Officer 474 350
Value: $1.09M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Perrin Steven
President
CEO / President 840 438
Value: $1.93M
Nov 21, 2024
Buy
Stock Option (right to buy)
A-Award
Little Paul Sean
Chief Financial Officer
C-Suite Officer 525 032
Value: $1.21M
Oct 29, 2024
Buy
Pre-funded Warrants to Purchase Common Stock
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 2 213 816
Value: $2K
Oct 29, 2024
Buy
Pre-funded Warrants to Purchase Common Stock
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 2 100 244
Value: $2K
Oct 29, 2024
Buy
Pre-funded Warrants to Purchase Common Stock
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 440 489
Value: $440
Oct 29, 2024
Buy
Pre-funded Warrants to Purchase Common Stock
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 440 489
Value: $440
Oct 29, 2024
Buy
Pre-funded Warrants to Purchase Common Stock
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 2 100 244
Value: $2K
Oct 29, 2024
Buy
Pre-funded Warrants to Purchase Common Stock
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 2 213 816
Value: $2K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Gros David-alexandre C
Chief Executive Officer
CEO / President 517 454
Value: $1.19M
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Little Paul Sean
Chief Financial Officer
C-Suite Officer 267 470
Value: $615.2K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Perrin Steven
President
CEO / President 428 148
Value: $984.7K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Smith Bryan E.
General Counsel, Corporate Sec
Officer 241 650
Value: $555.8K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Smith Bryan E.
General Counsel, Corporate Sec
Officer 241 650
Value: $555.8K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Perrin Steven
President
CEO / President 428 148
Value: $984.7K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Little Paul Sean
Chief Financial Officer
C-Suite Officer 267 470
Value: $615.2K
Jun 13, 2024
Buy
Stock Option (right to buy)
A-Award
Gros David-alexandre C
Chief Executive Officer
CEO / President 517 454
Value: $1.19M
May 09, 2024
Buy
Common Stock, $0.001 par value
P-Purchase
Bvf Partners L P/il
10 Percent Owner
10% Owner 1 031 385
Value: $2.44M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ELEDON PHARMACEUTICALS, INC.
Eledon Pharmaceuticals
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical tri...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE